Ruth Holm

Experimental Pathology

Group Leader: Ruth Holm Ph.D.

The research work of our group include gynaecological cancers and cell cycle-, apoptosis- and cell adhesion-markers, matrix metalloproteinases and HPV.

In addition to our own projects we are doing research work for other departments at Rikshospitalet-Radiumhospitalet Medical Center (RRMC) as well as for other hospitals.

Research projects

Molecular mechanisms in development and progression of ovarian cancers.

Molecular mechanisms in development and progression of vulvar cancers.

Print this page [332 visits]

News & events

Presentation of prestigious research project
Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside
May 16, 2012

GAP cancer conference in Oslo May 14-16
Global Academic Programs 2012
May 11, 2012

Trial lecture and disputation May 9th
Trevor Clancy
May 8, 2012

Study by Ane Hansen Kjenseth et al. featured on the cover of Journal of Biological Chemistry
May 7, 2012

Institute Seminar - Wednesday May 9th
Tor Erik Rusten
May 7, 2012

More news

Latest publications

Ruth Holm

Broberg ML, Holm R, Tønsberg H, Frølund S, Ewon KB, Nielsen AL, Brodin B, Jensen A, Kall MA, Christensen KV, Nielsen CU
Function and expression of the proton-coupled amino acid transporter Slc36a1 along the rat gastrointestinal tract: Implications for intestinal absorption of gaboxadol
Br J Pharmacol (in press)
PubMed 22577815

Schee K, Flatmark K, Holm R, Boye K, Paus E
Erratum to: Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
Tumour Biol (in press)
PubMed 22562266

Thomas N, Holm R, Müllertz A, Rades T
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)
J Control Release (in press)
PubMed 22405903

More publications